期刊文献+

Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies 被引量:13

原文传递
导出
摘要 Amorphous solid dispersions(ASDs)are popular for enhancing the solubility and bioavailability of poorly water-soluble drugs.Various approaches have been employed to produce ASDs and novel techniques are emerging.This review provides an updated overview of manufacturing techniques for preparing ASDs.As physical stability is a critical quality attribute for ASD,the impact of formulation,equipment,and process variables,together with the downstream processing on physical stability of ASDs have been discussed.Selection strategies are proposed to identify suitable manufacturing methods,which may aid in the development of ASDs with satisfactory physical stability.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第8期2505-2536,共32页 药学学报(英文版)
基金 supported,in whole or in part,by the Bill&Melinda Gates Foundation[No.OPP1159809,USA] supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award(No.R01AI132681,USA)
作者简介 Corresponding author:Sumit Kumar,Tel.:+12174167234,E-mail addresses:sumit.kumar@bms.com;Corresponding author:Qi(Tony)Zhou,Tel.:+17654960707,E-mail addresses:tonyzhou@purdue.edu
  • 相关文献

参考文献4

二级参考文献25

  • 1Bouquet,W.,Ceelen,W.,Fritzinger,B.,Pattyn,P.,Peeters,M.,Remon,J.P.,et al.(2007).Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion-Formulation and stability.European Journal of Pharmaceutics and Biopharmaceutics,66(3),391-397.
  • 2Brewster,M.E.,& Loftsson,T.(2007),Cyclodextrins as pharmaceutical solubilizers.Advanced Drug Delivery Reviews,59(7),645-666.
  • 3Busch,U.,Schmid,J.,Heinzel,G.,Schmaus,H.,Baierl,J.,Huber,C.,et al.(1998).Pharrnacokinetics of meloxicam in animals and the relevance to humans.Drug Metabolism and Disposition,26(6),576-584.
  • 4Corrigan,O.I.,& Stanley,C.T.(1982).Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems.Journal of Pharmacy and Pharmacology,34(10),621-626.
  • 5Davis,M.E.,& Brewster,M.E.(2004).Cyclodextrin-based pharmaceutics:Past,present and future.Nature Reviews Drug Discovery,3(12),1023-1035.
  • 6Defazio,S.,& Cini,R.(2002).Synthesis,X-ray structure and molecular modeling analysis of cobalt (Ⅱ),nickel (Ⅱ),zinc (Ⅱ) and cadmium (Ⅱ) complexes of the widely used anti-inflammatory drug meloxicam.Journal of the Chemical Society Dalton Transactions,(9),1888-1897.
  • 7Figueiras,A.,Carvalho,R.A.,Ribeiro,L.,Torres-Labandeira,J.J.,& Veiga,F.J.B.(2007).Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin.European Journal of Pharmaceutics and Biopharmaceutics,67(2),531-539.
  • 8Ghorab,M.M.,Abdel-Salam,H.M.,El-Sayad,M.A.,& Mekhel,M.M.(2004).Tablet formulation containing meloxicam and β-cyclodextrin:Mechanical characterization and bioavailability evaluation.AAPS PharmSciTech,5(4),E59.
  • 9Hanft,G.,Türck,D.,Scheuerer,S.,& Sigmund,R.(2001).Meloxicam oral suspension:A treatment alternative to solid meloxicam formulations.Inflammation Research,50(Suppl.1),S35-S37.
  • 10Jun,S.W.,Kim,M.S.,Kim,J.S.,Park,H.J.,Lee,S.,Woo,J.S.,et al.(2007).Preparation and characterization of simvastatin/bydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.European Journal of Pharmaceutics and Biopharmaceutics,66(3),413-421.

共引文献25

同被引文献141

引证文献13

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部